clinical trial · NCT04071847
Abbott DBS Post-Market Study of Outcomes for Indications Over Time
Abbott Medical Devices·—·recruiting·n = 1,000
Movement DisordersParkinson DiseaseEssential TremorTremorDystoniaPrimary DystoniaSecondary DystoniaDeep Brain Stimulation (DBS)
brief summary
The purpose of this international study is to evaluate long-term safety and effectiveness of Abbott deep brain stimulation (DBS) systems for all indications, including Parkinson's disease, essential tremor or other disabling tremor and dystonia.
started
Nov 26, 2019
primary completion
Sep 1, 2029
completion
Sep 1, 2030
last updated
Jan 8, 2026
detailed description
ADROIT is an international, prospective, multicenter, observational, post-market study intended to collect worldwide long-term safety and effectiveness data on subjects implanted with market-released Abbott DBS systems in routine clinical practice.
Subjects will be followed for 5 years after the initial programming visit.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol